Friday, April 19, 2024
MARKET UPDATE
Advertisement Topt

TheCable

Advertisement lead

Newspaper Headlines: Nigerian-made COVID vaccine for trial in November

Newspaper Headlines: Nigerian-made COVID vaccine for trial in November
August 26
06:14 2022

The UK peace meetings involving Nyesom Wike, governor of Rivers, and other Nigerian politicians dominated the cover pages of Nigerian newspapers.

The Nation says 22 former presidential hopefuls of the All Progressives Congress (APC) are set to unite to work for Bola Tinubu, APC presidential candidate. The newspaper reports that the federal government has asked Nigerians to stop going to Northern Cyprus.

The Punch says Atiku Abubakar, presidential candidate of the Peoples Democratic Party (PDP), met with Wike in London in order to resolve the feud with the governor. The newspaper reports that the COVID-19 vaccine developed by the federal government is set for trial in November.

Daily Trust says the United Nations has asked the federal government to increase the education budget to 20 percent. The newspaper reports that former President Goodluck Jonathan has asked politicians to put the country first as regards the 2023 elections.

The Guardian says Wike’s UK meeting with former President Obasanjo, Atiku and Peter Obi, presidential candidate of the Labour Party, has heightened political speculations ahead of the 2023 elections. The newspaper reports that access to high quality, reliable and sustainable water remains low in some states.

THISDAY says the Nigerian Upstream Petroleum Regulatory Commission (NUPRC) has called for declaration of a state of emergency on oil theft and underproduction. The newspaper reports that the white paper committee on Steve Oronsaye report has proposed an engagement with the national assembly to generate an understanding to streamline the creation of new agencies and commissions.

Click on the link below to join TheCable Channel on WhatsApp for your Breaking News, Business Analysis, Politics, Fact Check, Sports and Entertainment News!

Tags

0 Comments

No Comments Yet!

There are no comments at the moment, do you want to add one?

Write a comment

Write a Comment

error: Content is protected from copying.